ALSUntangled No. 18: Apoaequorin (Prevagen)

Richard Bedlack; Orla Hardiman; Terry Heiman-Patterson; Laurie Gutmann; Mark Bromberg; Lyle Ostrow; Gregory Carter; Edor Kabashi; Tulio Bertorini; Tahseen Mozaffar; Jeremy Shefner; et al.

doi:10.3109/17482968.2012.727302

Back

ALSUntangled No. 18: Apoaequorin (Prevagen)

Journal article

Peer reviewed

ALSUntangled No. 18: Apoaequorin (Prevagen)

Richard Bedlack, Orla Hardiman, Terry Heiman-Patterson, Laurie Gutmann, Mark Bromberg, Lyle Ostrow, Gregory Carter, Edor Kabashi, Tulio Bertorini, Tahseen Mozaffar, …

Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.14(1), pp.78-79

01/01/2013

DOI: https://doi.org/10.3109/17482968.2012.727302

PMID: 23030514

Abstract

Clinical Neurology

Life Sciences & Biomedicine

Neurosciences & Neurology

Science & Technology

Files and links (1)

url

https://doi.org/10.3109/17482968.2012.727302View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: ALSUntangled No. 18: Apoaequorin (Prevagen)
Creators: Richard Bedlack
Orla Hardiman
Terry Heiman-Patterson
Laurie Gutmann
Mark Bromberg
Lyle Ostrow
Gregory Carter
Edor Kabashi
Tulio Bertorini
Tahseen Mozaffar
Jeremy Shefner
et al.
Publication Details: Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.14(1), pp.78-79
Publisher: Taylor & Francis
Number of pages: 2
Grant note: Motor Neurone Disease Association Packard Center
Identifiers: 991006262396302656
Academic Unit: Neurology
Language: English
Resource Type: Journal article